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The sources and the catabohc pathways of cytoplasmrc pools of trtacylglycerols and cholesteryl esters have been comparatively mvesttgated in 
cultured fibroblasts from normal subjects and from pattents affected wtth neutral lipid storage disease (NLSD) and Wolman disease (WD). (i) 
Endogenously biosynthestzed triacylglycerols and cholesteryl esters were degraded extra-lysosomaily smce they were catabolized at srmilar rates 
in normal and in WD fibroblasts. In NLSD fibroblasts, the degradatton of endogenous triacylglycerols was severely deficient. whereas that of 
endogenous cholesteryl esters was in the normal range. (Ii) Reconstnuted htgh density lipoproteins (HDL) containing radiolabelled [‘Hltrtolein and 
cholesteryl [r4C]oleate were taken up by cultured fibroblasts and rapidly degraded in a non-lysosomal compartment. In NLSD fibroblasts the 
degradatton of HDL-[3H]trtolein was blocked whereas that of HDL-[‘“Clcholesteryl oleate was in the normal range. These data suggest that, (I) 
the cytoplasmtc pools of trtacylglycerols and cholesteryl esters origmate from HDL uptake and from endogenous btosynthests as well, (ii) 
cytoplasmic (non-lysosomal) trtacylglycerols and cholesteryl esters are degraded by two separate catabolic pathways. 
Triacylglycerol: Cholesteryl ester; High densrty lipoprotein: Low density hpoprotein; Ftbroblast; Neutral liptd storage disease: Wolman dtsease 
1. INTRODUCTION 
Cellular triacylglycerols (TAG) and cholesteryl esters 
(ChE) come from exogenous lipoproteins and from en- 
dogenous biosynthesis. These cellular TAG and ChE 
are metabolized in two separate subcellular compart- 
ments, the first one lysosomal, the second one cytoplas- 
mic [ 1,2]. 
The lysosomal compartment is supplied by apoB/E 
containing lipoproteins [l]. The role of the lysosome in 
the degradation of these neutral lipids has been directly 
investigated by using low density lipoproteins (LDL) 
containing radiolabelled or fluorescent [1,2] or unla- 
belled [3] lipids. In the lysosomal compartment both 
TAG and ChE are hydrolyzed by the lysosomal acid 
lipase/cholesterol esterase which is deficient in Wolman 
disease (WD) [ 1,461. 
The cytoplasmic compartment contains endogenous 
TAG and ChE which are biosynthesized from fatty 
acids taken up by cells or from products escaping the 
lysosome. The catabolic pathway of cytoplasmic TAG 
and ChE in intact cells has been investigated by ‘pulsee 
chase’ experiments with radiolabelled [7-lo] or fluores- 
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cent [l l] precursors [7.8]. At least three enzymatic sys- 
tems have been reported to be possibly involved in the 
degradation of TAG and ChE. The hydrolysis of cyto- 
plasmic TAG and ChE is catalyzed in several tissues by 
a single enzyme, namely the hormone-sensitive lipase 
[12-141. In contrast, in tissues or cells devoid of the 
hormone-sensitive lipase [12], for example in liver, 
cholesterol esterase and triacylglycerol lipase are sepa- 
rate enzymes [ 151. In mouse macrophagic cell lines, the 
conclusions are apparently conflicting, since the neutral 
lipase of WEHI cells seems to be identical to the 
hormone-sensitive lipase [13], whereas that of 5774 ex- 
hibits completely different properties from the hor- 
mone-sensitive lipase [16]. Furthermore some conflict- 
ing data have been reported concerning the hypothetical 
involvement of the acid lysosomal lipase in the degrada- 
tion of the cytoplasmic TAG and ChE [l-3,17- 211. 
Elsewhere radiolabelled ChE associated to high den- 
sity lipoproteins (HDL) are selectively taken up by cells 
and degraded extralysosomally [22,23]. However, to our 
knowledge. the uptake and the catabolic pools involved 
in the degradation of HDL-TAG are unknown. Fur- 
thermore, in cultured fibroblasts, the relationship be- 
tween the degradative pathways of cytoplasmic TAG 
and ChE is not clearly understood. 
In the present paper, the catabolic pathways of cyto- 
plasmic TAG and ChE have been compared using fi- 
broblasts from patients affected with Neutral lipid stor- 
age disease (NLSD) and WD. NLSD is a rare inherited 
metabolic disease characterized by the association of 
muscular weakness, ichthyosis, pancreatic failure and 
Publuhed by Elsevier Scrence Pubhshrrs B V 
Volume 328, number 3 FEBS LETTERS August 1993 
multisystemic triacylglycerol storage [24,25] without 
major impairment of the mitochondrial lipid metabo- 
lism [7,26]. TAG accumulation in NLSD cultured cells 
(fibroblasts and immortalized lymphoid cells) results 
from a severe defect in the degradation of endogenously 
biosynthesized TAG [7,11,27,28]. WD [29] is a rare au- 
tosomal disorder of lipid metabolism characterized by 
a severe acid lipase deficiency and a subsequent lyso- 
somal storage of TAG and ChE [4-61 originating 
mainly from exogenous lipoproteins (LDL or/and 
VLDL) [l-3]. 
The reported data suggest that (i) endogenously bio- 
synthesized ChE and TAG constitute two separate cyto- 
plasmic catabolic pools; (ii) HLD-triolein and HDL- 
ChE are internalized by fibroblasts and constitute also 
two independent cytoplasmic (i.e. non-lysosomal) cata- 
bolic pools probably identical to those of endogenous 
ChE and TAG. 
2. MATERIALS AND METHODS 
2.1. ?darerKh 
Radiolabelled cholesteryl [‘4C]oleate (SO mCi/mmol), [3H]triolein 
(26 Ci/mmol) were purchased from New England Nuclear (Les Ulis, 
France) or Amersham (Les Ulis, France), MTT (3-[4.5-dimeth- 
ylthiazol-2-yl]-2,5-diphenyltetrazolium bromide), bovine fatty acid- 
free albumin, oleic acid. triolein, pure taurocholate were from Sigma 
(St. Louis, MO, USA), Silica-gel G thin-layer chromatography analyt- 
ical plates were from Merck (Darmstadt. Germany), RPM1 1640. 
Phenol red-free RPM1 1640 (PRF-RPMI), fetal calf serum, glutamine, 
streptomycin and penicillin were from Gibco (Cergy-Pontoise, 
France); Ultroser G from IBF (Villeneuve-la-Garenne, France); cell 
culture flasks were from Nunc (distributed by Polylabo-Block. Stras- 
bourg, France); Hydragel was from Sebia (Issy-les-Moulineaux 
France): Picofluor was from Packard (Rungis, France). and the other 
reagents and organic solvents were from Merck or Prolabo (Paris, 
France). 
2.2. Cell culture 
Fibroblasts from patients affected with NLSD (Bo. and Dem.) were 
kmdly provided by Drs. J.M. Mussini and S. Billaudel. CHU Nantes, 
France and by Dr. B. Winchester (Instttute of Chtld Health. London, 
UK); those of WD (GM1606) were purchased from the NIGMS 
Human Genetics Mutant Cell Repository (Camden, NJ), those of 
Cholesteryl ester storage disease (DM) were kindly provided by Profs. 
C. Borrone and P. Durand (Istituto Gaslim, Genova, Italy) and those 
of normal individuals (nl. n2 and n3) were from our laboratory. 
Fibroblasts were grown at 37°C in 5% C02/95% air in RPM1 1640 
medium with penicillin (100 U/ml), streptomycin (100 &ml), gluta- 
mine (2 pmol/ml) and supplemented with 10% heat-inactivated fetal 
calf serum or 2% Ultroser G (a synthetic lipoprotein-free serum substi- 
tute) under the previously used conditions [7,11]. Cell viability was 
determined by the MTT test [30]. 
2.3. Lipoprotern isolation and label&g wth [jH]triolein and cholest- 
eryl [“C]oleate 
LDL. HDL and lipoprotein-depleted serum (LPDS) were isolated 
from human pooled sera by ultracentrifugation (Beckman L8-70 Ul- 
tracentrifuge) according to Have1 [31], extensively dialyzed, sterihzed 
by filtration (0.2 pm Millipore membrane) and were stored at 4°C 
under nitrogen (up to 3 weeks). The purity of lipoproteins was con- 
trolled by electrophoresis on Hydragel. HDL were labelled with 
[‘Hltriolein and cholesteryl [‘4C]oleate according to the procedure of 
Krueger et al. [32]. The final labelling was 23,000 dpm [‘Hltriolein (1.8 
nmol)/pg apoA-I and 1.700 dpm cholesteryl [?Z]oleate (0.4 nmol)/pg 
apoA-I. LDL were labelled with [‘Hltriolein according to a procedure 
derived from that of Roberts et al. [33]: briefly 10 ml human serum 
was incubated overnight at 37°C with [‘Hltriolein (10’ dpm). Then 
LDL were isolated by ultracentrifugation as indicated above. The final 
labelling was around 11,000 dpm [3H]triolein/pg apoB. ApoA-I and 
apoB concentrations were determined by immunonephelometry 
(Behring system). 
2 4. Cellular uptake and metabohsm of [3H]oleic acrd 
The optimal culture conditions to induce a large cellular biosynthe- 
sis and accumulation of radiolabelled TAG and ChE were derived 
from previous reports [7,9.34] and from preliminary experiments. Fi- 
broblasts were pre-incubated for 24 h in RPMI-1640 containing 2% 
Ultroser G, 10% LPDS and cholesterol (130 nmol/ml). then ‘pulsed’ 
for 12 h with 30 nmol/ml radiolabelled [‘Hloleic acid ( IO4 dpm/nmol 
oleic acid). At the end of the incubation time. cells were washed twice 
in PBS containing 5 mg/ml bovine serum albumin (fatty acid-free) and 
twice m PBS, and homogenized in water. The cell-associated radioac- 
tivity was determmed by liquid scintillation counting (in 5 ml Picofluor 
using a Packard counter model Tricarb 4530) and the lipids analyzed. 
2.5. Cellular uptake of lipoprotein-[3H]triolern and xholesteryl 
[“Cjoleate 
For determinmg the cellular uptake of HLD-[‘Hltriolein <holest- 
eryl [‘4C]oleate. fibroblasts were incubated for 12 h in RPMI-1640 
containing 2% Ultroser G and increasing concentrations of HDL- 
[‘Hltriolem and -cholesteryl [‘4C]oleate. At the end of this pulse pe- 
riod, cells were carefully washed (as above indicated). harvested and 
the cell-associated radioactivity was counted and the lipids analyzed. 
2 6. Llpld extraction and analysis 
Cellular lipids were extracted with chloroform/methanol (2/l. v/v) 
according to the procedure of Folch et al. [35] and separated by 
thin-layer chromatography on Silicagel G plates, using the following 
solvent systems: chloroform/methanol/water (100/42/6, v/v/v) for the 
separation of the phosphohpids, and petroleum ether/diethyl ether/ 
acetic acid (80/20/l, v/v/v) for the separation of the neutral lipids. 
Radiolabelled lipids were counted directly on the thin-layer chroma- 
tography plate using a radiochromatoscanner Berthold (model LB 
285) under the previously used conditions [7] 
Protein concentrations were determmed by the method of Lowry et 
al. [36]. 
3. RESULTS 
3.1. Metabolism of endogenously biosynthesized TAG 
and ChE 
The conditions of pre-incubation with cholesterol 
and pulse with [3H]oleic acid have been defined in order 
to induce a concomitant biosynthesis and accumulation 
of radiolabelled TAG and ChE. The lipid concentra- 
tions used in the reported experiments did not exhibit 
any cytotoxic effect to the human fibroblasts during the 
period of the experiment (higher concentrations of 
cholesterol and/or oleic acid cannot be used because of 
their cytotoxicity to fibroblasts). At the end of the pulse, 
the radiolabelled TAG represented 15-30% of the lipid- 
associated radioactivity in normal fibroblasts and 
nearly 50% in NLSD fibroblasts. Radiolabelled ChE 
represented 7-l 5% of the lipid-associated radioactivity 
in normal and also NLSD fibroblasts. 
During the 48 h chase period (in serum-free medium 
containing 2% Ultroser G), the cell-associated radioac- 
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tivity decreased slowly (Fig. 1A). The levels of radiola- 
belled polar lipids were almost constant during the 
chase (Fig. 1B). The radiolabelled TAG decreased rap- 
idly (half-life 5 + 1 h) in fibroblasts from normal sub- 
jects and from those with WD, whereas in NLSD fi- 
broblasts they decreased very slowly (half-life higher 
than 100 h). These results are consistent with the hy- 
pothesis of a selective block of the degradation pathway 
of endogenously biosynthesized TAG in NLSD fibro- 
blasts (Fig. 1C). In marked contrast, the degradation of 
the radiolabelled ChE was quite similar in controls and 
in NLSD fibroblasts (Fig. 1D). In conclusion, these 
data strongly suggest that, in normal human fibroblasts. 
endogenous TAG and ChE are degraded in the cyto- 
plasmic compartment (since no accumulation was ob- 
served in WD cells) by two different enzymatic systems: 
(i) the lipase system which is defective in NLSD fibro- 
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Fig 1. Tlme<ourse of the degradation and turnover of endogenously 
biosynthesized hplds in cultured fibroblasts from normals (filled sym- 
bols), NLSD (open circles) and WD (open squares) patients. Cultured 
fibroblasts were pre-Incubated with cholesterol (130 nmol/ml for 24 
h) and ‘pulsed’ with [7H]01eic acid (30 nmol/ml for 12 h). Then fibro- 
blasts were grown for 48 h (chase period) m RPM1 1640 supplemented 
with 2% Ultroser G (wIthout any oleic acid or serum albumin). At the 
mdlcated times, cells were harvested and the radiolabelled cellular 
hpids were analyzed (thin-layer chromatography and radlochromato- 
scanner) as Indicated m sectlon 2. The amounts of radiolabeled hplds 
(in A, total hplds; in B. polar lipids; in C. TAG: in D. ChE) are 
expressed as nmol of [‘HJoleic acid incorporated m each class of hptds 
per mg of cell protein. In inset of A are reported the protems per dish 
(Petri dishes. 3.5 cm diameter). Each point represents the mean of four 
separate experiments (t S.E.M ). 
0- 0- 
0 100 200 0 100 200 
HDL-[SH]triolein/[l4C]cholesteryl oleate (pg apoA-l/ml) 
Fig. 2. Uptake of [‘Hltrlolem (A) and cholesteryl [“‘Cloleate (B) mcor- 
porated mto HDL by cultured fibroblasts from normals (filled sym- 
bols), WD (open squares) and NLSD (open circles) Flbroblasts were 
‘pulsed’ with mcreasmg concentrations of HDL--[lH]trlolem or 
cholesteryl [‘JC]oleate (up to 200 fig apoA_I/ml) for 12 h After 
washing and harvestmg the cells, the cell-associated radioactlvlty was 
determined by liquid scmtillation countmg and expressed as nmol olelc 
acld/mg cell protein The results are the mean of two separate expen- 
ments (k SE M.) 
blasts; (ii) a cholesteryl ester hydrolyzing system which 
is not deficient in NLSD fibroblasts. 
3.2. Uptukr and degrudation of’ HDL-l’H]triolein und 
HDL. partially delipidated and reconstituted with 
[‘Hltriolein and cholesteryl [“Cloleate according to the 
procedure of Krieger et al. [33], were used for studying 
the cellular uptake and subsequent degradation of 
[3H]triolein and cholesteryl [“Cloleate contained in 
HDL. The electrophoresis of these reconstituted HDL 
demonstrated that both radiolabelled lipids were really 
associated with HDL (data not shown). The cellular 
uptake of both radiolabelled lipids, [jH]triolein and 
cholesteryl [‘“Cloleate associated to HDL, was quite 
similar in all the cells used here (Fig. 2). 
HDL-[3H]triolein and -cholesteryl [‘“Cloleate taken 
up by the fibroblasts were rapidly degraded by normal 
and WD fibroblasts (half-life around 6 ? 1 h for HDL- 
[‘Hltriolein and less than 2 h for HDL-cholesteryl 
[‘4C]oleate) (Fig. 3). In NLSD fibroblasts the degrada- 
tion of the internalized HDLP[‘H]triolein was severely 
deficient (as shown by the constant level of internalized 
HDL-[3H]triolein and by the lack of labelling of 
phospholipids). In contrast, the degradation of the in- 
ternalized HDL-cholesteryl [“C]oleate was in the nor- 
mal range (Fig. 3B). Note that the level of HDL-[‘Hltri- 
olein undegraded at the end of the pulse was higher in 
NLSD than in controls cells because of the degradation 
block in NLSD cells. In normal cells, under the condi- 
tions used, the major part of [‘Hloleic acid liberated by 
hydrolysis of the internalized HDL-[‘Hltriolein was re- 
utilized in newly synthesized phospholipids. In NLSD 
fibroblasts, the accumulation of undegraded HDL- 
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nl 172 nl 172 WD NLSD 
Fig. 3. Degradation of HDL-[‘Hltriolein or -cholesteryl [‘%Z]oleate by 
fibroblasts from normal (nl,n2). WD (W) and NLSD (N) patients. 
Cultured fibroblasts were pulsed for 12 h with a fixed amount of 
HDL-[‘Hltriolein or -cholesteryl [‘4C]oleate (200 pug apoA-I/ml) 
under the same conchtions as Fig. 2. Then cells were washed and 
‘chased’ m the standard culture medium. Cells were harvested at the 
indicated times (filled bars, time 0 of the chase; stippled bars, 6 h 
chase), and lipids extracted and separated by TLC as mdlcated m Fig. 
1. (A) [‘H]Triolein, (B) cholesteryl [“Cloleate For comparison the 
degradation of LDL-[‘Hltriolein performed under similar experimen- 
tal con&ions is shown in the mset to A. The results are the mean of 
three separate experiments (f S.E.M.). 
[‘Hltriolein demonstrates that HDL-[3H]triolein is in- 
ternalized by fibroblasts without prior hydrolysis (since 
in this case the liberated [3H]oleic acid would be incor- 
porated into phospholipids even in NLSD cells, as in 
Fig. 1). 
All these results suggest that (i) HDL-[3H]triolein and 
xholesteryl [‘4C]oleate are effectively taken up and in- 
ternalized by cultured fibroblasts; (ii) the internalized 
HDL-[3H]triolein and xholesteryl [‘4C]oleate are de- 
graded at a normal rate in WD fibroblasts, thus in a 
non-lysosomal compartment (referred to as the cyto- 
plasmic compartment); (iii) the internalized HDL- 
[3H]triolein is degraded in normal fibroblasts but not in 
NLSD fibroblasts, suggesting that HDLp[3H]triolein is 
degraded by the same catabolic pathway as en- 
dogenously biosynthesized TAG; (iv) HDL-cholesteryl 
[‘4C]oleate is not blocked in NLSD cells, thus the cyto- 
plasmic degradation pathways of cholesteryl [‘4C]oleate 
and [3H]triolein are independent. 
In order to confirm that the catabolic pools of cyto- 
plasmic TAG and ChE are independent of the lyso- 
somal compartment, we have compared the degrada- 
tion of radiolabelled LDL-[3H]triolein in fibroblasts 
from normal, NLSD and WD patients. As expected, the 
LDL-[3H]triolein degradation was blocked in WD cells, 
whereas it was in the normal range in NLSD cells (inset 
of Fig. 3A). 
4. DISCUSSION 
The reported data suggest that the cytoplasmic pools 
of TAG and ChE (i) are supplied by the endogenous 
biosynthesis of TAG and ChE and by the uptake of 
exogenous HDL-TAG and HDL-ChE; (ii) are de- 
graded by two separate catabolic pathways, each being 
independent of lysosomal catabolism. 
Endogenously biosynthesized TAG and ChE are de- 
graded independently of the lysosomal compartment 
since they do not accumulate in WD cells. The lyso- 
somal accumulation of neutral lipids in WD fibroblasts 
results from lipids taken up through the apoB/E recep- 
tor-mediated pathway which is connected to the lyso- 
somal compartment [l-6]. HDL-TAG and HDL-ChE 
taken up by fibroblasts, probably through a high-affin- 
ity HDL receptor pathway [37-41], are degraded at a 
normal rate in WD fibroblasts, and thus are catabolized 
in a cytoplasmic compartment completely independent 
of the lysosome. This conclusion is in good agreement 
with previous reports [22,37,42-45], but is in disagree- 
ment with some conflicting earlier reports claiming that 
the degradation of HDL neutral lipids could be ly- 
sosome dependent [4648]. Moreover, under the used 
conditions (serum-free medium) we did not observe any 
appreciable reverse transport of the radiolabelled TAG 
and ChE outside the cell (i.e. retro-endocytosis) since (i) 
no significant amount of radiolabelled lipid was recov- 
ered in the culture medium; (ii) the radioactivity was 
recovered in the cellular phospholipids (the radiola- 
belled free fatty acids liberated by the hydrolysis of 
HDL- [3H]triolein and -cholesteryl [‘4C]oleate being re- 
utilized in the cellular biosynthesis of phospholipids). 
In NLSD fibroblasts, the concomitant catabolic 
block of internalized HDL-[3H]triolein and of the en- 
dogenously biosynthesized TAG strongly suggests that 
TAG from the two different sources (endogenously bio- 
synthesized TAG and HDL-TAG) reach the same cyto- 
plasmic (extra-lysosomal) catabolic pool and are de- 
graded by the same lipase system which is deficient in 
NLSD cells. In contrast, endogenously biosynthesized 
ChE and HDL-cholesteryl [‘4C]oleate internalized by 
fibroblasts, probably by the ‘selective uptake’ described 
by Pittman’s group [21,22]. did not accumulate in 
NLSD fibroblasts nor in WD fibroblasts. This suggests 
that these ChE are degraded in a cytoplasmic (extra- 
lysosomal) compartment through a catabolic pathway 
involving a neutral cholesteryl esterase independent of 
the lipase system. 
In conclusion, the use of human fibroblasts from 
NLSD and WD patients allowed us to demonstrate that 
the cytoplasmic pools of TAG and ChE originate from 
(at least) two sources. the first one arising from en- 
dogenous biosynthesis and the second one from ex- 
ogenous HDL taken up by cells. NLSD fibroblasts ex- 
hibited a severe deficiency of the degradation of en- 
dogenous and HDL-TAG as well. In contrast HDL- 
ChE and endogenous ChE were degraded at a normal 
rate in NLSD. This demonstrates the existence of two 
separate (non-lysosomal) catabolic pathways for cyto- 
plasmic TAG and ChE in cultured human fibroblasts. 
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